Epilepsy & seizure disorders Board decisions

The Board granted an effective date of September 10, 2010, for a total disability rating due to individual unemployability (TDIU) and basic eligibility to Dependents' Educational Assistance (DEA).

The Board remands the claims for service connection for erectile dysfunction, myocarditis, and a seizure disorder due to insufficient medical evidence regarding toxic exposures during service.

The Board remands the claims for service connection for various neurological conditions, as additional medical evidence is needed to determine if these conditions are related to or aggravated by the Veteran's service-connected lumbar spine disability.

The Board granted service connection for a left temporal lobe mass and epilepsy with intractable seizures as secondary to the left temporal lobe mass.

The Board remands the claims for compensation under 38 U.S.C. § 1151 for stroke and seizure disorder due to a need for an addendum opinion that addresses the Veteran's theory of entitlement.

The Board granted eligibility for the direct payment of fees to the appellant from past due benefits awarded in the portion of a July 2023 rating decision granting higher ratings for epilepsy and migraine headaches, but denied it for lumbar strain and cognitive disorder.

The Veteran is granted special monthly compensation (SMC) based on the need for aid and attendance from June 18, 2019 to October 7, 2022 due to his service-connected conditions requiring regular assistance.

The Board remands the claims for further development and to correct pre-decisional duty-to-assist errors.

The Board denied service connection for coronary artery disease, hypertension, a seizure disability, peripheral vascular disease, chronic kidney disease, and diabetes mellitus as the record does not show that these conditions were incurred in or caused by service.

The Board denied the appellant's request for a higher level of special monthly compensation (SMC) based on the need for regular and aid and attendance due to brain cancer.

The Board granted earlier effective dates for the service-connected PTSD, TBI, and TDIU but denied earlier effective dates for the migraine headaches, petit mal epilepsy with vertigo, and hypertension.

The appeal was denied for a rating in excess of 30 percent for scars, and the claims for increased ratings for TBI and headaches, as well as service connection for seizures, were remanded for further development.

The Board dismissed the appeal for an initial 10 percent disability rating for service-connected psychomotor epilepsy and denied increased, compensable ratings for a scar on the right forehead and service connection claims for sciatic nerve conditions in both lower extremities.

The Board remands the claim for a neurological disorder, to include cognitive impairment, deficits in memory and concentration, and seizures, for further evidentiary development.

The Board remands the claims for service connection for a left finger condition, seizures, skin cancer, and brain injury (including TBI) due to insufficient evidence.

The Board granted an effective date of August 15, 2011, for the award of service connection for peritoneal adhesions and associated scar of the mid-abdomen but denied earlier effective dates for a seizure disorder and DEA benefits. A rating of 30 percent was also granted for peritoneal adhesions.

The Veteran's respiratory conditions, including asthma and sleep apnea, are rated at 100 percent disabling from June 18, 2018.

The Board remands the claims for service connection for a seizure disorder and entitlement to a TDIU due to deficiencies in the previous decision.

The Board granted the Veteran's appeal for service connection and an earlier effective date, awarding a 100% rating for acoustic schwannoma status post resection with vertigo and staggered gait to include right hemiplegia stroke and bilateral hearing loss.

The Board granted service connection for a seizure disorder with left-sided weakness and encephalopathy secondary to the Veteran's service-connected brain tumor, effective August 25, 2018. The Board denied an initial rating higher than 30 percent for the brain tumor and a rating higher than 70 percent for PTSD.